Remove merck-kgaa-suffers-cdmo-slump-after-sharp-drop-covid-related-sales-cfo-says
article thumbnail

Merck KGaA suffers CDMO slump after 'sharp drop' in COVID-related sales, CFO says

Fierce Pharma

The division took a major hit from production timing and COVID-related sales downturns.

Sales 205